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ARND B. BUCHWALD,  MD 
GOttingen, Germany 
Objectives. We tested the hypothesis that reduced acute platelet 
deposition after angioplasty results in reduced late neointimal 
proliferation. 
Background. Platelet-mediated mechanisms contribute to 
smooth muscle cell proliferation and migration. 
Methods. Indium-Ill-labeled platelets were injected 16 h 
before coronary stent angioplasty in 10 G6ttinger minipigs: group 
1 (n = 5) = beparin (100-U/kg bolus) before angioplasty; group 2 
(n = 5) = recombinant hirudin (CGP 39393, 1.0-mg/kg body 
weight bolus intravenously), followed by subcutaneous doses of 
6 to 10 mg/kg every 8 h. Furthermore, stent angioplasty was 
performed in coronary arteries of 16 minipigs: group 3 (n = 5, nine 
stents) = 100 U/kg heparin only; group 4 (n = 5, 10 stents) = 
1-mg/kg bolus hirudin before and 45 rain after angioplasty; group 
5 (n = 6, 11 stents) = hirudin (l-mg/kg intravenous bolus) before 
and 45 rain after angioplasty, followed by 6 to 10 mg/kg subcuta- 
neously every 8 h. 
Results. In segments with deep arterial injury, the number of 
platelets/angioplasty segment in group 2 after 72 h (mean 21, 
range 9.7 to 39.7 × 106) was significantly less than that in group 
1 (mean 375, range 72 to 787 x 106). Morphometric analysis after 
4 weeks showed no difference between groups in degree of vessel 
wall injury. Mean (-+SD) neointimal thickness was 0.70 __. 
0.06 mm in group 3 and was significantly reduced in both group 4 
(0.46 -+ 0.11 mm) and group 5 (0.48 _+ 0.21 mm). 
Conclusions. The direct thrombin inhibitor hirudin signifi- 
cantly reduces platelet deposition up to 72 h after coronary stent 
angioplasty. A hirudin bolus alone as well as continued subcuta- 
neous administration for 14 days substantially reduced neointi- 
mal proliferation compared with heparin 4 weeks after coronary 
stent angioplasty in minipigs. 
(J Am Coil Cardiol 1995;26:1747-54) 
Since its introduction in 1978 (1), coronary angioplasty can 
now be performed in more and more complex lesions with a 
primary success rate >90%. Despite enormous technical ad- 
vances and the use of new interventional techniques and 
devices, such as directional coronary atherectomy (2), excimcr 
laser coronary angioplasty (3), stent implantation (4,5) or 
rotational ablation (6,7), restenosis remains the major limita- 
tion of long-term success. Thus, 30% to 50% of patients 
develop restenosis in the first 6 months after balloon angio- 
plasty. Mechanisms underlying this restenosis nclude passive 
elastic recoil, which may result in diminution of the maximal 
achieved lesion diameter, depending on the composition of the 
lesion (i.e., fibrocellular, sclerotic or calcified) (8-10). Balloon- 
induced vascular injury induces neointimal proliferation by 
several mechanisms: Balloon inflation results in plaque rup- 
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ture, commonly producing dissection of the intima and media. 
Thrombi form, and platelets are deposited and provide a 
potent nidus on which mural thrombus organization and 
collagen matrix formation can occur (11). In addition, mito- 
genic factors are released by platelets, endothelial cells and 
stretched smooth muscle cells, resulting in migration and 
proliferation of smooth muscle cells (12). Several growth 
factors (partly stored in the alpha-granules of platelets) are 
involved in smooth muscle cell proliferation: platelet-derived- 
growth factor (13), transforming rowth factor-beta (14) and 
epidermal growth factor (15). A stimulatory effect on smooth 
muscle cell proliferation has also been demonstrated for 
thrombin (16). 
Hirudin, a specific thrombin inhibitor, has been shown to 
reduce fibrin deposition and platelet deposition after balloon- 
induced arterial injury in a carotid angioplasty model (17) as 
well as after coronary stent angioplasty in minipigs (18). 
We hypothesized that a reduction of platelet and fibrin 
deposition might result in decreased neointimal proliferation 
in a minipig coronary angioplasty model. We studied 1) the 
effectiveness of subcutaneous hirudin in maintaining reduced 
thrombus formation for 3 days after angioplasty; and 2) 
neointimal proliferation after angioplasty in minipigs treated 
with subcutaneous hirudin for 14 days. 
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Methods  
Animal model. Minipigs of the G6ttingen strain (25 to 
40 kg, 12 to 24 months old) were studied. After intramuscular 
sedation with azaperone (10 mg/kg body weight), a central 
venous line was inserted through an ear vein. Sixty milliliters of 
blood was withdrawn from animals; platelets were separated 
and were reinjected together with iodine-125-1abeled fibrino- 
gen. Animals were placed under general anesthesia for the 
angioplasty procedure. 
Angioplasty. Animals were sedated by an intramuscular 
injection of azaperone (10 mg/kg) and intravenous piritramide 
(Dipidolor) (7 rag). Anesthesia was induced after orotracheal 
intubation and ventilation by a mixture of halothane (0.8% to 
1.5%), nitrous oxide (69%) and oxygen (30%) (Sulla 19 
respirator, Dr~iger, Germany). Blood gases were regularly 
monitored, and ventilation was adjusted to maintain blood 
gases in the physiologic range. 
The right carotid artery was surgically exposed, and an 8F 
coronary guide catheter was advanced into the ascending 
aorta. Tantalum stents (Wiktor-stents, Medtronic, Dtisseldorf, 
Germany), premounted on a balloon with a nominal inflated 
diameter of 3, 3.5 or 4 mm, were placed into coronary artery 
segments of slightly smaller diameter (0.3 to 0.5 mm less) 
under fluoroscopic guidance. Stents were inflated twice at 8 to 
10 atm for a total of 30 s. Balloons were then deflated and 
withdrawn. 
Thereafter the carotid arteu, was ligated, and the animals 
were returned to their cages after recovery from anesthesia. 
After 12 or 72 h (short term) or 4 weeks (long term), 
angiography was repeated to confirm patency of the stented 
artery. Thereafter, the hearts were excised, immediately 
perfused with phosphate-buffered saline solution at a pres- 
sure of 100 mm Hg and then perfusion fixed with buffered 
4% formalin. 
Labeled platelets and fibrinogen. Autologous platelets 
were labeled according to a method modified from Laue et al. 
(19). Blood was drawn into acid citrate dextrose (5:1), and the 
platelets were separated from 60 ml. Finally, 3.7 MBq 
(100 /xCi) of indium-ill oxine was added, resulting in a 
labeling efficiency of 76 _+ 4~ (mean _+ SD) and platelet 
recovery of 51 _+ 3%. 
Sterile water (1 ml) was added to lyophilized human 
fibrinogen (1.2 rag), which was ]abeled with 4.07 MBq 
(110 p, Ci) of iodine-125 30 min before intravenous injection. 
Equal amounts of activity were injected in each study: 3 MBq 
of indium-Ill-labeled platelets and 3 MBq of iodine-125- 
labeled human fibrinogen. 
Blood samples drawn after 15 min and 2, 4, 6, 12, 18 and 
24 h after injection as well as at the end of the 12- or 72-h 
short-term protocol were counted in a gamma well counter. A
double-window technique was used with spilldown correction 
(30% from the 247-keV indium-Ill window into the 35-keV 
iodine-125 window). A symmetric 50-keV window centered 
around the 247-keV peak was used for indium-Ill, with a 
symmetric 20-keY window centered around 35 keV for iodine- 
125. Typical (background-corrected) count rates 24 and 90 h 
after injection were between 1,000 and 2,000 and between 500 
and 1,000 counts/min, respectively. Stent angioplasty was per- 
formed after platelet-bound indium-Ill activity and plasma 
iodine-125 activity had reached steady-state conditions, at a 
mean of 16 h (range 14 to 18) after injection. Radiochemicals 
were obtained from Amersham Buchler, Braunschweig, Ger- 
many. 
Anticoagulation. All animals received a single bolus of 
250 mg of acetylsalicylic a id before insertion of the arterial 
catheter. Starting on the day after operation, they were given 
100 mg of acetylsalicylic a id/day in tablet form. 
Short-term protocol. In five minipigs (group 1), anticoag- 
ulation consisted of a bolus injection of unfractionated heparin 
(100 U/kg) given before insertion of the guiding catheter. Five 
animals in group 2 received a bolus injection of hirudin 
(1 mg/kg, CGP 39393, recombinant desulfatohirudin, Ciba 
Geigy, Basel, Switzerland) instead. This intravenous bolus was 
repeated 45 to 60 min later when the activated partial throm- 
bin time had decreased below 50 s. In two group 2 animals, a 
subcutaneous bolus of 6 mg/kg of hirudin was given 3 h later, 
and anesthesia was maintained until the animals were killed at 
12 h after angioplasty. Two group 1 animals were also killed 
after 12 h. 
After recovery from anesthesia, three group 2 animals were 
given hirudin subcutaneously (6 to 10 mg/kg) and then every 
8 h for 72 h at doses adjusted to maintain activated partial 
thromboplastin ime >1.8 times control evels. In group 1 the 
remaining three animals were given subcutaneous saline injec- 
tions. Animals were randomly allocated to either anticoagula- 
tion regimen. 
At the end of each experiment, stent angioplasty segments 
were excised (exactly at the proximal and distal borders of the 
stent) from the hearts after perfusion fixation in 4% buffered 
formalin at a pressure of 100 mm Hg. The segments thus 
obtained were of comparable l ngths of 15 to 17 mm and 
were counted for radioactivity, as described for the blood 
samples. 
Long.term protocol. Minipigs were randomly assigned to 
receive either unfractionated heparin as a bolus (100 U/kg 
intravenously, group 3, n = 5) or recombinant hirudin (1 mg/kg 
intravenously, group 4, n = 5), followed by subcutaneous 
injections of 0.9% saline solution every 8 h for 2 weeks. 
Animals in group 5 (n = 6) received an intravenous bolus 
injection of hirudin before angioplasty and a second bolus 
(1 mg/kg) 45 to 60 rain later. After angioplasty, subcutaneous 
injections of 6 to 10 mg/kg were given and repeated every 8 h 
to maintain the activated partial thromboplastin time pro- 
longed to >1.8 times above control evels for 2 weeks. Repeat 
angiography and excision of the hearts were performed after 4 
weeks. 
Histoiogic studies. All stents were further processed as 
previously described (20). In brief, after dehydration i  graded 
alcohol concentrations, they were embedded inmethylmethac- 
rylate. Six sections/stent -8  txm thick were prepared without 
prior removal of the stent wire, and elastica van Gieson 
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Table 1. Laboratory Variables in Heparin-Treated (group 1) and Hirudin-Treated (group 2) Minipigs 
Before and 72 h After Angioplasty 
Group 1 Group 2 
(heparin, n - 3) (hirudin, n = 3) 
Before 72 h After Before 72 h After 
Angioplasty Angioplasb, Angioplasty Angioplasty 
Hemoglobin (g/liter) 121 ± 14 112 _+ 20 109 _+ 22 87 ± 22 
Hematocrit 0.35 ± 0.05 0.34 _+ 0.05 0.29 _+ 0.07 0.25 _+ 0.08 
Fibrinogen (tLmol/liter) 7.74 ± 2.62 9.88 _+ 2.92 7.06 _+ 2.76 8.77 _+ 1.49 
Platelet count (× 109/liter) 437 ± 135 499 ± 108 411 ± 108 451 ± 98.8 
Hemoglobin and hematocrit showed atenden~, to decrease in the hirudin group after 72 h. Fibrinogen concentration 
and platelet counts were not different in the two groups. Data presented are mean value ± SD. 
staining was performed. This procedure allowed microscopic 
analysis of damage limited to the intima or extending into the 
media. Morphometric analysis of the free lumen and vessel 
areas (lumen plus intima plus media) was performed in six 
slices/stent. Vessel wall area was calculated as the difference 
between vessel area and free lumen area. Injury was evaluated 
according to a score proposed by Schwartz et al. (21). Each 
stent strut/slice was assigned a numerical value: 0 -- intact 
internal elastic lamina; 1 = lacerated internal elastic lamina, 
media compressed but not lacerated; 2 = lacerated internal 
elastic lamina and media, intact external amina; 3 = large 
laceration of the media, stent strut in the adventitia. Mean 
injury scores were calculated as the quotient of the sum of 
weights for each wire and the number of wires present. 
Laboratory testing. Blood samples for hemoglobin, hema- 
tocrit, fibrinogen and platelet counts were taken before angio- 
plasty and 12 or 72 h later in the short-term protocol groups 1 
and 2. The same variables were measured in the long-term 
groups 3 days and 4 weeks after angioplasty. Activated partial 
thromboplastin me was measured before anticoagulant drugs 
were given and 20 min and 1 and 3 h later, before each 
subcutaneous dose in the first 4 postoperative days and at the 
end of the study period. 
Statistics. The Kruskal-Wallis test was used for compari- 
son of the laboratory variables in the three long-term protocol 
groups. Within-group values at different times were compared 
by the Wilcoxon test. A p value <0.05 was considered to be 
statistically significant. Platelet and fibrin deposition i  angio- 
plasty segments from minipigs after 72 h as well as neointimal 
thickness in the long-term protocol groups 3, 4 and 5 were 
analyzed using a multivariate mixed linear model (22). Covari- 
ables were 1) anticoagulation, 2) target vessel (right, left 
circumflex or left anterior descending coronary artery), 3) 
balloon size, and 4) injury of the vessel wall. Data were 
analyzed for equality at the 5% level by the multiple test 
procedure of Scheff6 (23). Anticoagulation was considered as a 
fixed factor; all other covariables were considered to be 
random. The square of the stent size was modeled as a fixed 
factor to account for differences in stent surface. The multiple 
5% level was taken to indicate statistical significance. 
Resu l ts  
Platelet and fibrin deposition 12 and 72 h after coronary 
stent implantation. In 10 animals tent angioplasty was per- 
formed in 26 coronary arteries. Two additional nimals, one in 
each group, died 30 rain and 6 h after angioplasty. In one of 
these animals ventricular fibrillation was observed during 
repair of the neck wound. External defibrillation was ineffec- 
tive. In the second animal the same mechanism ost likely 
resulted in sudden death because both animals had occlusive 
spasm during implantation that could not be stopped by 
intracoronary nitroglycerin. These animals were not included 
in the analysis. 
Laboratory variables. Platelet counts, fibrinogen, hemoglo- 
bin and hematocrit were not significantly different in the two 
groups. Although the platelet count remained stable through- 
out the experimental period, fibrinogen values increased 
slightly in both groups. In hirudin-treated animals, a decrease 
in hemoglobin by 22 g/liter and in the hematocrit by 0.04 as a 
result of mild bleeding from the neck wound was observed 72 h 
after stent angioplasty (Table 1). 
Activated partial thromboplastin time in heparin-treated 
animals (group 1) was still prolonged at 1 h after stent 
angioplasty and then returned to normal. In hirudin-treated 
animals, activated partial thromboplastin ime was prolonged 
to >2 times the control value after 2 h and remained pro- 
longed to >1.8 times for the experimental course of 72 h 
(Table 2). 
After analysis for radioactivity, six slices/stent were ana- 
lyzed histologically, and the injury score was determined. 
Segments were grouped as deep arterial injury if two or more of 
the six analyzed slices had an injury score ->2 or as superficial 
injury if only one or none of the six slices had a score ->2. 
Platelet deposition. The mean values and ranges of values 
for platelets/segment are shown in Figure 1. In animals acri- 
ficed after 12 h, platelet deposition was similar for segments 
injured only superficially (score <2) in both groups, but with 
deep injury (score >2), segments from heparin-treated animals 
showed four times more platelets deposited than segments 
from hirudin-treated animals. These results are in good agree- 
ment with our earlier observations (18) on the effect of hirudin 
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Table 2. Activated Partial Thromboplastin Time Values (multiples of baseline -+ SD) 
Control 1 h After 3 h After 4 h After 8 h After 
Group Value Angioplasty Angioplasty SC Hirudin SC Hirudin 
1 (heparin,  - 5) 1 2.~ _+_ 0.3* 1.2 + 0.l 
2 (hirudin, n 5) I 2.1 _+ 0.4* 2.0 + 0.3* 2.7 + 0.4* 2.2 + 0.4* 
(n = 3) (n = 3) 
3 (heparin, n 5) I 2.7 ± {).4* 1.1 _+. 0.1 1.0 -+ 0.2 1.1 _+ 0.3 
4 (hirudin bolus, n - 51 1 2.3 +_ 05* 1.2 +_ 0.2 1.2 -+ {).3 1.0 _+ 0.2 
5 (hirudin, n - 6) 1 2.1 + 0.3* 2.0 +_ 0.3* 2.5 _+ 0.5* 2.1 _+ 0.3* 
*p < 0.05 versus control value. Data presented are mean value + SD. SC = subcutaneous. 
after this time period. We did not perform statistical analysis of 
these values because only two animals/group were analyzed 
after this 12-h period in the current study. After treatment with 
subcutaneous hirudin for 72 h, platelet deposition/segment 
remained in the range of the values after 12 h (range 9.7 to 
39.7 x 106 platelets, mean 21) in the presence of deep injury. 
In contrast, it increased to 375 × 106 platelets (range 72 to 787) 
for segments in the heparin-treated minipigs showing an injury 
score >2 (p < 0.05). Segments with superficial injury only 
(score <2) showed no major increase compared with the 12-h 
values. 
Fibrin deposition. Fibrin deposition closely resembled the 
pattern described for platelct deposition and is shown in 
Figure 2. The four segments in the heparin group (injury score 
>2) had an average of 157 /xg (range 91 to 282) of fibrin 
deposited after 12 h. This deposition amounted to 1,856 /,g 
(range 750 to 3,700) fibrin after 72 h. Animals in the hirudin 
group with an injury score >2 showed less fibrin deposition 
after 12 h (mean 16/zg fibrin/segment, range 6.8 to 28.8) as 
well as after 72 h (680/,g fibrin/segment, range 210 to 800). 
Similar to platelet deposition, fibrin deposition was greater in 
deeply injured segments than in vessels without deep injury. 
Figure 1. Platelet (Pit.) deposition at 12 and 72 h after angioplasty 
(mean values [columns] and ranges [vertical lines]) in treatment 
groups 1 and 2 on a logarithmic scale. Segments were grouped for the 
presence or absence of deep arterial injury (score >2 or <2). Columns 
after 12 h represent two segments each from two animals in both 
treatment groups. After 72 h, three segments inthe hirudin and four in 
the heparin group showed superficial injury (score <2), and six in the 
hirudin group and five in the heparin group showed eep injury (score 
>2). *p < 0.05. Hatched bars - hirudim open bars = heparin. 
8001 PIt" x 10 e ] 
100 1 ~-u.~ I 
,oi 
1 . . . . . . . .  
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Neointimal proliferation 4 weeks after coronary angio- 
plasty. Laboratory variables. The values for hemoglobin, he- 
matocrit, fibrinogen and the platdet counts did not differ 
among the three groups before angioplasty. Hemoglobin and 
hematocrit decreased significantly in the first 3 postoperative 
days in those animals with long-term hirudin as a result of 
bleeding from the neck wound. No renal or gastrointestinal 
bleeding nor any other hematoma formation was observed. At 
the end of the study period (4 weeks), these laboratory 
variables were not different among the three groups (Tables 3 
and 4). 
In all three groups activated partial thromboplastin time 
was <18 s at baseline and prolonged 1 h after start of anticoag- 
ulation (more than twice control value). In the heparin-treated 
minipigs, activated partial thromboplastin time was normal 3 h 
after implantation. In animals in group 4 (hirudin bolus), acti- 
vated partial thromboplastin time prolongation after 1 h was 
more pronounced than in group 3 but had also normalized after 
3 h. Group 5 minipigs had activated partial thromboplastin time 
values more than twice the control value after 3 h. During 
long-term treatment with subcutaneous hirudin, mean activated 
partial thromboplastin time values before the next injection were 
>1.8 times the control value. Hirudin doses were adopted to 
maintain minimal activated partial thromboplastin time >1.8 
times the control value (Table 2). 
l-Iistologic analysis. In 16 animals, stent angioplasty was 
performed in 30 coronary arteries, and these were patent 4 
weeks later. None of the animals died prematurely. 
In six slices/angioplasty segment, the injury scores did not 
Figure 2. Fibrin deposition at 12 and 72 h after angioplasty. *p < 0.05, 
Format and symbols as in Figure 1. 
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Table 3. Hemoglobin and Hematocrit  Values Before and After Coronary Angioplasty 
Baseline 3 Days After Angioplasty 4 Weeks After Angioplasty 
Group Hb (g/liter) Hct Hb (g/liter) Hct Hb (g/liter) Het 
3 (heparin, n = 5) 117 + 17 0.34 ± 0.04 118 ± 18 0.32 ± 0.02 106 ± 8 0.33 ± 0.04 
4 (hirudin bolus, n - 5) 120 ± 12 0.37 +__ 0.03 114 - 8 0.33 ± 0.03 124 ± 11 0.35 -+ 0.03 
5 (hirudin, n - 6) 111 = 9 0.32 ± 0.03 86 ± 3*t 0.25 ± 0.01*t 119 _+ 6 0.34 _+ 0.02 
*p < 0.05 versus baseline values, tp < 0.05 versus baseline values and values at 4 weeks after angioplasty and values of groups 3 and 4 at the same time. Data 
presented are mean value + SD. Hb = hemoglobin; Hct= hematocrit. 
differ among the groups and averaged 1.84 _+ 0.21 in group 3 
(heparin); 1.84 _+ 0.26 in group 4 (hirudin bolus); 1.83 _+ 0.37 
in group 5 (long-term hirudin treatment). The neointimal 
proliferative response was measured by microscopic examina- 
tion and determination f mean neointimal thickness. Mean 
neointimal thickness (Fig. 3) was significantly lower in both 
hirudin groups (group 4, mean 460 /~m, range 330 to 690; 
group 5, mean 480 /zm, range 290 to 680) than in animals 
treated with heparin (mean 700 tzm, range 660 to 820). 
Vessel wall area accounted for 75.8% (range 74% to 96%) 
in the heparin-treated animals. In hirudin-treated minipigs, the 
vessel wall area amounted to 56% (range 39% to 71%) and 
53% (range 42% to 68%) (Fig. 4). In all three groups the 
neointima was characterized histologically by a fibrocellular 
proliferation. Although the proliferative response in groups 4 
and 5 was morphologically similar to that observed in group 3, 
the extent of this response was markedly lower in the hirudin- 
treated groups. Typical histologic sections through an angio- 
plasty segment ingroups 3 and 5 are shown in Figures 5 and 6. 
Discuss ion  
Restenosis after coronary angioplasty is the result of a 
complex response of the artery to a more or less severe trauma. 
Besides elastic recoil leading to an early loss of lumen gained, 
this trauma is followed by activation of the coagulation cascade 
resulting in the formation of a mural thrombus (8,24). The 
amount of thrombus formed can contribute to restenosis either 
by an organization and replacement by invading and prolifer- 
ating medial smooth muscle cells or by the release of factors 
stimulating migration and proliferation of smooth muscle cells 
from the media (25) or, most likely, both. 
The present study tested the hypothesis that the quantity of 
thrombus i related to the extent of late neointimal prolifera- 
tion. Reduction of thrombus formation was achieved by using 
the direct thrombin inhibitor hirudin as an anticoagulant 
rather than the standard clinical practice of a heparin bolus. 
Hirudin reduces early thrombus formation after deep arterial 
injury in carotid arteries ignificantly more effectively than 
heparin, as originally shown by Heras et al. (17). This finding 
reflects everal advantages of direct thrombin inhibitors over 
heparin. They can inhibit thrombin bound to fibrin clots or 
extracellular matrices, which is relatively resistant to heparin; 
in addition, they are not inhibited by release of platelet factor 
4 from activated platelets and do not require antithrombin III
(26,27). 
Platelet and fibrin deposition. We previously showed (18) 
that hirudin also reduces thrombus formation after 12 h in a 
minipig coronary angioplasty model (18). The present study 
confirms the results of our earlier study of platelet and fibrin 
deposition 12 h after angioplasty. Although the number of 
angioplasty segments analyzed after 12 h in the present study is 
small (n = 6/group), platelet deposition in deeply injured 
segments i almost identical: The range of values in hirudin- 
treated animals was 14 to 33 x 106/segment i  he earlier study 
and 12 to 20 x 106/segment i  the present study. In heparin- 
treated animals, ranges were 53 to 164 x 106 and 78 to 98 x 
106/segment, respectively. This effect is maintained for up to 
72 h by subcutaneous administration f hirudin continuously 
prolonging the activated partial thromboplastin time. Assess- 
ment of platelet deposition after longer periods was not 
possible in our model because of the degradation of the 
short-lived indium. The present study shows not only that 
hirudin reduces platelet and fibrin deposition, but that this 
effect ranslates into a pronounced reduction i  late neointimal 
proliferation compared with that for heparin. 
Platelet deposition and neointimal proliferation. Hirudin 
was either given as a single bolus only or for 2 weeks after 
Table 4. Fibrinogen and Platelet Values Before and After Coronary Angioplasty 
Baseline 3 Days After Angioplasty 4 Weeks After Angioplasty 
Fibrinogen Platelets Fibrinogen Platelets Fibrinogen Platelets 
Group (~mol/liter) (× 10~/liter) (btmol/liter) ( × 109/liter) (/zmol/liter) ( x 109/liter) 
3 (heparin, n - 5) 6.53 _+ 2.75 505 = 86 9.53 + 2.09* 512 ± 28 8.88 +- 1.38 499 ± 83 
4 (hirudin bolus, n - 5) 6.18 _+ 1.35 510 z 14.8 8.24 _+ 0.50* 51)0 + 83 8.32 ± 0.62* 580 ± 141 
5 (hirudin, n = 6) 5.41 _+ 1.77 529 = 48 8./)3 _+ 1.44" 504 + 14.7 6.94 ± 1.71" 539 ± 12.8 
*p < 0.05 versus baseline values. Values in each treatment group were tested for significant differences using the Wilcoxon test. Measurements at each time point 
in different groups were compared using the Kruskal-Wallis test for significant differences. Data presented are mean value ± SD. 
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Figure 3. Mean values (columns) and ranges (vertical lines) for 
neointimal thickness in groups 3, 4 and 5. Numbers (n) correspond to 
the number of angioplasty segments in each group. *p < 0.05 versus 
group 3 at the 5% level. 
angioplasty, a period after which reendotheliazation in this 
model is complete as assessed by electron microscopy in three 
animals (data not shown). The effect on neointimal prolifera- 
tion was similar in both groups, that is, prolonging the acti- 
vated partial thromboplastin time for <3 h (Table 2) resulted 
in the same reduction in neointimal formation as did long-term 
hirudin administration. These data suggest that it is mainly the 
platelet and fibrin deposition immediately after angioplasty 
that determines the degree of late neointimal proliferation. 
The continuation of anticoagulation u til reendotheliazation is 
achieved seems to provide no additional effect. This interpre- 
tation is in accordance with several observations. We were 
unable to show an antiproliferative effect of hirudin on smooth 
muscle cells in culture (data not shown). The increase in 
platelet deposition between 12 and 72 h is minor compared 
with the number present at 12 h in the heparin-treated animals 
(i.e., the major effect of hirudin on platelet deposition was 
achieved in the first few hours after angioplasty), and subse- 
quent anticoagulation has only a minor effect on thrombus 
formation. Moreover, thrombus formed after vascular injury 
Figure 4. Mean values (columns) and ranges (vertical ines) for vessel 
wall area in groups 3, 4 and 5. Numbers (n) correspond to the number 
of angioplasty segments ineach group. *p < 0.05 versus group 3 at the 
5% level. 
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Figure 5. Section through an angioplasty segment after 4 weeks 
(heparin group 3). Neointimal proliferation is maximal at the site of 
severe vessel damage (arrowhead). Stent wires are black and partly 
"dropped out" from the thin sections. Elastica van Gieson stain x40, 
reduced by 35%. 
has been reported (28) to be largely resolved by 48 h. However, 
this interpretation may be valid only for segments with no 
residual lumen narrowing, as was observed in the present 
model. 
The thrombogenicity of a largely irregular lumen in human 
coronary segments after angioplasty with a certain degree of 
residual stenosis might be substantially higher. This concept is 
supported in a study by Willerson et al. (29). In a dog model of 
combined coronary endothelium injury and external constric- 
tion, they reported cyclic flow variations as indirect evidence 
for the amount of platelet deposition. These flow variations 
were present in some animals for several days after injury, 
indicative of repetitive thrombus formation and resolution in 
this model with an external constrictor causing persistent 
Figure 6. Section through an angioplasty segment after 4 weeks 
(hirudin group 5). Medial laceration is also associated with the most 
pronounced proliferation (arrowhead); however, the extent of this 
response is markedly reduced compared with that in the heparin 
treatment group (Fig. 5). There is only minimal poliferative reaction 
around a strut not penetrating the internal elastic lamina (open arrow). 
Elastica van Gieson stain ×40, reduced by 35%. 
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lumen narrowing after endothelial injury (29). Only if nearly 
complete limination of cyclic flow variations by thromboxane 
and serotonin antagonists was achieved was subsequent eo- 
intimal proliferation decreased. 
Nonetheless, the observation of a profound reduction in 
late proliferation obtained with a hirudin bolus alone has 
important implications for a major concern of this anticoagu- 
lation approach, namely, bleeding. Meyer et al. (30) recently 
showed that local hirudin administration with a very low dose 
compared with systemic application also results in a significant 
reduction in platelet deposition in a pig carotid angioplasty 
model. If subsequent proliferation is also reduced, this ap- 
proach could further educe bleeding complications. Evidence 
for a role of thrombin inhibition in late neointimal prolifera- 
tion after angioplasty was previously provided by Waiters et al. 
(31), who showed that the thrombin inhibitors hirudin and 
PPACK reduced neointimal proliferation in rabbit aortas. 
Similarly, Sarembock et al. (32) demonstrated a reduction of 
neointimal proliferation i  rabbit iliac arteries by 50% after 
treatment with hirudin. 
Coronary angioplasty model. In the present study we used 
intracoronary stent angioplasty to reproducibly create a deep 
arterial injury. Previous tudies have shown that the degree of 
late neointimal proliferation i pigs depends on the degree of 
vessel wall injury. Leaving the internal elastic membrane intact 
results in a very modest neointimal proliferation, whereas deep 
tears into the media are associated with a much more pro- 
nounced proliferative response. This finding is in contrast to 
results obtained in smaller animal models such as the rat 
carotid artery. Here, apparently superficial injury limited to the 
endothelium already results in extensive neointimal formation 
(33). However, ballooning of porcine coronaries with signifi- 
cantly oversized (->30%) balloons is associated with a signifi- 
cant incidence of vessel closure and animal death in the early 
hours after angioplasty (34). We lost every third animal to 
sudden death with histoiogic evidence of thrombotic vessel 
occlusion before switching to the stent angioplasty model. 
Apparently, stenting prevents vessel closure in the majority of 
cases because we lost only 2 of 28 animals prematurely in the 
present study. However, it might be argued that stent angio- 
plasty cannot readily be compared with balloon angioplasty 
because of a higher thrombogenicity of and a foreign body 
reaction to the stent wire. Although we certainly cannot otally 
rule out such effects, we and others (35) found a histologic 
appearance of the neointima closely resembling results after 
balloon angioplasty and no evidence for foreign body reaction 
as a major contributor to the proliferative response. In con- 
trast, the close correlation of the amount of proliferation and 
degree of vessel injury produced by stent struts suggests that 
the injury to the media mainly determines the amount of 
proliferation, and not any kind of foreign body reaction. If the 
latter were the case, struts over an intact internal elastic lamina 
should also be surrounded by a marked proliferative response, 
which we did not observe. 
Nonetheless, because stent angioplasty in the clinical situ- 
ation is associated with an increased incidence of thrombotic 
vessel closure compared with balloon angioplasty, this model 
certainly involves a higher thrombogenic potential. Extrapola- 
tion to human balloon angioplasty can be done only with 
appropriate caution. In a recent multicenter study (36), the 
effect of hirudin in patients with unstable angina undergoing 
coronary angioplasty was assessed. Restenosis was not differ- 
ent between hirudin and heparin treatment after 7 months. 
However, the incidence of early events was reduced in the 
hirudin group (36). 
Summary. The present study shows that in a porcine 
coronary stent angioplasty model, reduced acute thrombus 
formation isassociated with a significantly reduced neointimal 
proliferative response after 4 weeks. This finding could be of 
potential value for designing new anticoagulation strategies in 
human coronary angioplasty aiming at reduced acute platelet 
and fibrin deposition to reduce late restenosis. 
We thank Christina Schgtfer and Petra Sejdija for expert echnical assistance in 
the preparation of the histologic slices. 
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